FIRM NAMES LEADER OF DEVELOPMENT.Byline: Daily News VALENCIA - Kenneth T. Denich is the new director of business development for Valencia's AlleCure Corp. a wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. of MannKind Corp. Denich will work directly with AlleCure President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. Stephen J. McCormack, leading the company's developing corporate strategy, identifying new business opportunities and negotiating business deals. Denich has 25 years of experience as a scientific research and development executive. Trained in molecular biology molecular biology, scientific study of the molecular basis of life processes, including cellular respiration, excretion, and reproduction. The term molecular biology was coined in 1938 by Warren Weaver, then director of the natural sciences program at the Rockefeller and immunology, Denich also has extensive experience in corporate and fiscal planning, technology and strategy development, as well as patent research. ``Ken is a valuable addition to our senior management team,'' McCormack said. ``AlleCure's pipeline is rich with advanced products, several of which will be developed through corporate partnerships. Ken's unique experience and training fits well with AlleCure's vision as an integrated biopharmaceutical company.'' AlleCure is part of MannKind Corp., a biopharmaceutical company founded by Alfred E. Mann Alfred E. Mann (born 1925, Portland, OR), who is also known as Al Mann, is an American entrepreneur and philanthropist. He is a billionaire. Born and raised in Portland, his father was English and mother Polish. , with operations developing innovative therapeutics and drug delivery systems to treat cancer, diabetes, allergies, and other diseases. AlleCure discovers and develops therapeutics to treat conditions caused by immune system immune system Cells, cell products, organs, and structures of the body involved in the detection and destruction of foreign invaders, such as bacteria, viruses, and cancer cells. Immunity is based on the system's ability to launch a defense against such invaders. imbalance. The company's proprietary allergy vaccine system may be capable of treating specific allergies with only three to six injections. The company plans to bring its AlleVax allergy vaccines to market, starting with treatments for allergies to insect venom, pollens and dust mites. AlleCure is also developing biotherapeutics and drugs for treatment of immune-related diseases such as asthma and autoimmune disorders Autoimmune Disorders Definition Autoimmune disorders are conditions in which a person's immune system attacks the body's own cells, causing tissue destruction. such as Crohn's disease, multiple sclerosis and rheumatoid arthritis. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion